Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity

scientific article published in June 2001

Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1161/01.ATV.21.6.961
P698PubMed publication ID11397704
P5875ResearchGate publication ID11941324

P2093author name stringBergeron J
Alméras N
Després JP
Nadeau A
Bogaty P
Lemieux I
Pascot A
Prud'homme D
P433issue6
P407language of work or nameEnglishQ1860
P921main subjectobesityQ12174
P304page(s)961-967
P577publication date2001-06-01
P1433published inArteriosclerosis, Thrombosis, and Vascular BiologyQ4797542
P1476titleElevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity
P478volume21

Reverse relations

cites work (P2860)
Q36641503'Metabolically healthy obesity': origins and implications
Q43165906A 52-week prospective, cohort study of the effects of losartan with or without hydrochlorothiazide (HCTZ) in hypertensive patients with metabolic syndrome
Q37620043A Useful Tool As a Medical Checkup in a General Population-Bioelectrical Impedance Analysis
Q38076251A consideration of biomarkers to be used for evaluation of inflammation in human nutritional studies
Q35711283A novel anti-inflammatory natural product from Sphaeranthus indicus inhibits expression of VCAM1 and ICAM1, and slows atherosclerosis progression independent of lipid changes
Q36822591Abdominal Obesity and Association With Atherosclerosis Risk Factors: The Uberlândia Heart Study.
Q36682671Abdominal obesity and metabolic syndrome
Q46422661Abdominal obesity predicts declining insulin sensitivity in non-obese normoglycaemics: the Insulin Resistance Atherosclerosis Study (IRAS).
Q37267248Abdominal obesity: the cholesterol of the 21st century?
Q34551435Abdominal subcutaneous and visceral adipose tissue and insulin resistance in the Framingham heart study
Q42953757Acute resistance exercise results in catecholaminergic rather than hypothalamic-pituitary-adrenal axis stimulation during exercise in young men.
Q54597679Adipocytokines in rheumatoid arthritis and obesity
Q33835439Adipokines are associated with lower extremity venous disease: the San Diego population study.
Q34384883Adipokines: molecular links between obesity and atheroslcerosis
Q51921520Adiponectin gene expression and adipocyte NF-kappaB transcriptional activity in elderly overweight and obese women: inter-relationships with fat distribution, hs-CRP, leptin and insulin resistance.
Q38220213Adipose tissue changes in obesity and the impact on metabolic function
Q52558707An integrative approach to investigate the association among high-sensitive C-reactive protein, body fat mass distribution, and other cardiometabolic risk factors in young healthy women.
Q37578266Appropriateness of waist circumference and waist-to-hip ratio cutoffs for different ethnic groups
Q34388277Are risk factors associated with outcomes in pancreatic cancer?
Q34974413Association between Abdominal Fat (DXA) and Its Subcomponents (CT Scan) before and after Weight Loss in Obese Postmenopausal Women: A MONET Study
Q44684059Association between C-reactive protein, anthropometric and lipid parameters among healthy normal weight and overweight postmenopausal women in Montenegro
Q44713977Association between fasting glucose and C-reactive protein in middle-aged subjects
Q35717014Association between oxidized LDL, obesity and type 2 diabetes in a population-based cohort, the Health, Aging and Body Composition Study
Q39721292Association of C-reactive protein with body fat, diabetes and coronary artery disease in Asian Indians: the Chennai Urban Rural Epidemiology Study (CURES-6).
Q30355036Association of Central Adiposity With Adverse Cardiac Mechanics: Findings From the Hypertension Genetic Epidemiology Network Study.
Q37261739Association of obesity-mediated insulin resistance and hypothalamic volumes: possible sex differences.
Q44768008Associations among work-related stress, cortisol, inflammation, and metabolic syndrome.
Q33938878Behavioural treatments for chronic systemic inflammation: effects of dietary weight loss and exercise training
Q36381096Biomarkers of obesity and subsequent cardiovascular events
Q92462247Biomarkers of subclinical atherosclerosis in patients with psoriatic arthritis
Q33630100Biphasic response of mitochondrial biogenesis to oxidative stress in visceral fat of diet-induced obesity mice
Q44969867Body fat and C-reactive protein levels in healthy non-obese men.
Q34985484Body fat distribution and inflammation among obese older adults with and without metabolic syndrome
Q42366197Body fat distribution, in particular visceral fat, is associated with cardiometabolic risk factors in obese women
Q34062129Brain, liver, and serum salusin-alpha and -beta alterations in Sprague-Dawley rats with or without metabolic syndrome
Q38473714Bringing JUPITER down to earth
Q47182880C-reactive protein and coronary artery disease: influence of obesity, caloric restriction and weight loss
Q46044968C-reactive protein and tumor necrosis factor-alpha in relation to insulin-mediated glucose uptake, smoking and atherosclerosis
Q44594411C-reactive protein in young, apparently healthy men: associations with serum leptin, QTc interval, and high-density lipoprotein-cholesterol
Q46406619C-reactive protein, insulin resistance and risk of cardiovascular disease: a population-based study
Q46595366CRP reduction following gastric bypass surgery is most pronounced in insulin-sensitive subjects
Q45286980CRP: star trekking the galaxy of risk markers
Q51497326Calcium supplementation does not affect CRP levels in postmenopausal women--a randomized controlled trial.
Q36957415Cardiovascular Risk in Women With PCOS.
Q36662926Challenges associated with metabolic syndrome
Q64100119Change in Plant-Based Diet Quality Is Associated with Changes in Plasma Adiposity-Associated Biomarker Concentrations in Women
Q35660000Changes in erythrocyte sedimentation rate, white blood cell count, liver enzymes, and magnesium after gastric bypass surgery
Q37849235Chronic inflammation is correlated with percentage of body fat independent of the burden of infection
Q47760005Chronic low-grade peripheral inflammation is associated with severe nicotine dependence in schizophrenia: results from the national multicentric FACE-SZ cohort.
Q36550333Chronic sub-clinical inflammation in the abdominal adipose tissue - Evaluation of inflammatory cytokines and their link with insulin resistance in metabolically obese South Indians: A cross-sectional observational study
Q47185422Claimed effects, outcome variables and methods of measurement for health claims on foods proposed under European Community Regulation 1924/2006 in the area of appetite ratings and weight management
Q31140518Clinical and pathophysiological consequences of abdominal adiposity and abdominal adipose tissue depots
Q46163361Concurrent improvement of the metabolic syndrome and lower urinary tract symptoms upon normalisation of plasma testosterone levels in hypogonadal elderly men.
Q36434450Contribution of CB1 blockade to the management of high-risk abdominal obesity
Q55263145Coronary Disease and Metabolic Syndrome.
Q57761427Diabetes y enfermedad cardiovascular
Q42592049Dietary cholesterol worsens adipose tissue macrophage accumulation and atherosclerosis in obese LDL receptor-deficient mice
Q37349807Dietary determinants of subclinical inflammation, dyslipidemia and components of the metabolic syndrome in overweight children: a review
Q46496031Direct comparison of dietary portfolio vs statin on C-reactive protein
Q31113992Does body mass index (BMI) influence the Ankylosing Spondylitis Disease Activity Score in axial spondyloarthritis?: Data from the SPACE cohort
Q38261196Ectopic visceral fat: a clinical and molecular perspective on the cardiometabolic risk
Q55395282Effect of 8 Weeks Soccer Training on Health and Physical Performance in Untrained Women.
Q36929124Effect of Acupuncture on Body Weight Reduction and Inflammatory Mediators in Egyptian Obese Patients
Q37352857Effect of exercise on abdominal fat loss in men and women with and without type 2 diabetes
Q35441429Effect of increased leptin and C-reactive protein levels on mortality: results from the National Health and Nutrition Examination Survey
Q42164961Effect of insulin therapy on endothelium-dependent dilation in type 2 diabetes mellitus
Q46948236Effectiveness of weight loss in the elderly with type 2 diabetes mellitus
Q36941827Effects of Low-Fat Diets Differing in Protein and Carbohydrate Content on Cardiometabolic Risk Factors during Weight Loss and Weight Maintenance in Obese Adults with Type 2 Diabetes
Q28297798Effects of exercise and diet on chronic disease
Q33708384Effects of lifestyle measures, antiobesity agents, and bariatric surgery on serological markers of inflammation in obese patients
Q38454661Effects of simvastatin on C-reactive protein in mixed hyperlipidemic and hypertriglyceridemic patients
Q36216863Effects of weight loss and pharmacotherapy on inflammatory markers of cardiovascular disease
Q44479466Elevated concentrations of C-reactive protein in subjects with type 2 diabetes mellitus are moderately influenced by glycemic control
Q48025354Endogenous thrombin potential in polycystic ovary syndrome: the association to body mass index, insulin resistance, and inflammation.
Q35087494Endothelial dysfunction and the metabolic syndrome
Q35813629Endothelial dysfunction, inflammation and diabetes
Q51489577Endothelial lipase is associated with inflammation in humans.
Q44360330Enhanced erythrocyte adhesiveness/aggregation in obesity corresponds to low-grade inflammation.
Q84644791Evaluation of lasting high levels of CRP among the patients with metabolic syndrome
Q35201559Evaluation of the combined use of adiponectin and C-reactive protein levels as biomarkers for predicting the deterioration in glycaemia after a median of 5.4 years
Q36815079FUNCTIONAL HYPERCORTISOLISM, VISCERAL OBESITY, AND METABOLIC SYNDROME.
Q80827639Flow-resistant red blood cell aggregation in morbid obesity
Q55424979Gemcabene, a First-in-Class Hypolipidemic Small Molecule in Clinical Development, Attenuates Osteoarthritis and Pain in Animal Models of Arthritis and Pain.
Q52592593Gemcabene, a first-in-class lipid-lowering agent in late-stage development, down-regulates acute-phase C-reactive protein via C/EBP-δ-mediated transcriptional mechanism.
Q53198210Genetic contribution to C-reactive protein levels in severe obesity.
Q34270507Genome-wide association for abdominal subcutaneous and visceral adipose reveals a novel locus for visceral fat in women
Q51449727Genome-wide linkage analysis for circulating levels of adipokines and C-reactive protein in the Quebec family study (QFS).
Q52948768Haemostatic and inflammatory alterations in familial hypercholesterolaemia, and the impact of angiotensin II infusion.
Q34454547Health consequences of visceral obesity
Q35197824Health risks of lipodystrophy and abdominal fat accumulation: therapeutic possibilities with leptin and human growth hormone
Q45848309Hepatocyte growth factor and interferon-γ inducible protein-10 are related to visceral adiposity.
Q50057787Hepatocyte nuclear factors as possible C-reactive protein transcriptional inducer in the liver and white adipose tissue of rats with experimental chronic renal failure.
Q44477341High expression of complement components in omental adipose tissue in obese men.
Q51483133Hip circumference is an important predictor of plasma C-reactive protein levels in overweight and obese Taiwanese women.
Q37364955Hypertriglyceridemic waist phenotype predicts increased visceral fat in subjects with type 2 diabetes
Q92378297Impact of Estrogens on the Regulation of White, Beige, and Brown Adipose Tissue Depots
Q30309693Impact of the GH-cortisol ratio on the age-dependent changes in body composition
Q35078877Impact of weight loss diet associated with flaxseed on inflammatory markers in men with cardiovascular risk factors: a clinical study
Q51326584Improvement of atherosclerotic markers in non-diabetic patients after bariatric surgery.
Q35707614Inflammation and race and gender differences in computerized tomography-measured adipose depots
Q37198826Inflammation as a cardiovascular risk factor and pulse wave velocity as a marker of early-stage atherosclerosis in the Japanese population
Q34578077Interactions between C-reactive protein genotypes with markers of nutritional status in relation to inflammation
Q73392899Interpretation of circulating C-reactive protein levels in adults: Body Mass Index and gender are a must
Q64096918Interrelation of chemerin and TNF-α with mtDNA copy number in adipose tissues and blood cells in obese patients with and without type 2 diabetes
Q24796491Intimal redox stress: accelerated atherosclerosis in metabolic syndrome and type 2 diabetes mellitus. Atheroscleropathy
Q48110940Intrauterine growth restriction combined with a maternal high-fat diet increased adiposity and serum corticosterone levels in adult rat offspring
Q44075438Involvement of leptin in the association between percentage of body fat and cardiovascular risk factors.
Q36070412Lipaemia, inflammation and atherosclerosis: novel opportunities in the understanding and treatment of atherosclerosis
Q61449481Lipid Oxidation Assessed by Indirect Calorimetry Predicts Metabolic Syndrome and Type 2 Diabetes
Q44898907Low-grade systemic inflammation impairs arterial stiffness in newly diagnosed hypercholesterolaemia
Q34248896Lymphatic system: a vital link between metabolic syndrome and inflammation
Q64087695Metabolic Risk Factors and Left Ventricular Diastolic Function in Middle-Aged Chinese Living in the Tibetan Plateau
Q34643136Metabolic effects of a growth hormone-releasing factor in obese subjects with reduced growth hormone secretion: a randomized controlled trial
Q34287907Metabolic health reduces risk of obesity-related cancer in framingham study adults
Q53621412Metabolic syndrome aggravates the increased endothelial activation and low-grade inflammation in subjects with familial low HDL.
Q34031701Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training
Q36012953Metabolic syndrome: the danger signal in atherosclerosis
Q47217380MiR-27b-3p Regulation in Browning of Human Visceral Adipose Related to Central Obesity.
Q39622961Morphological Changes in the Carotid Artery Intima after Gastric Bypass for Morbid Obesity.
Q34149741Novel anti-adipogenic activity produced by human fibroblasts.
Q92024524Nutrition Therapy in Managing Pregnant Women With Gestational Diabetes Mellitus: A Literature Review
Q28079661Nutrition, insulin resistance and dysfunctional adipose tissue determine the different components of metabolic syndrome
Q37604873Nutritional programming of the metabolic syndrome
Q22252221Obesity and Thrombosis
Q37352219Obesity and inflammation: the effects of weight loss
Q76394099Obesity is the major determinant of elevated C-reactive protein in subjects with the metabolic syndrome
Q37455451Obesity, coffee consumption and CRP levels in postmenopausal overweight/obese women: importance of hormone replacement therapy use.
Q44279278Obesity, fasting plasma insulin, and C-reactive protein levels in healthy children
Q36053970Obesity, lutein metabolism, and age-related macular degeneration: a web of connections
Q81585501Obesity-related correlation between C-reactive protein and the calculated 10-y Framingham Coronary Heart Disease Risk Score
Q38200416Our stolen figures: the interface of sexual differentiation, endocrine disruptors, maternal programming, and energy balance
Q51498823Persisting effects on fasting glucose levels and insulin sensitivity after 6 months of discontinuation of a very low-dose GH therapy in adults with severe GH deficiency.
Q92083501Physical Activity, Cardiorespiratory Fitness, and the Metabolic Syndrome
Q33594449Physical exercise reduces the expression of RANTES and its CCR5 receptor in the adipose tissue of obese humans
Q73588894Plasma C-reactive protein concentrations in relation to 5-year body weight change among children: the Taipei Children Heart Study
Q47313074Platelet Counts and Liver Enzymes After Gastric Bypass Surgery.
Q36663553Platelet counts and liver enzymes after bariatric surgery
Q50728522Polycystic ovary syndrome and low-grade inflammation with special reference to YKL-40.
Q51487065Postprandial variations of plasma inflammatory markers in abdominally obese men.
Q61799934Potential impact of the joint association of total bilirubin and gamma-glutamyltransferase with metabolic syndrome
Q91386621Predicting longevity using metabolomics: a novel tool for precision lifestyle medicine?
Q36342333Prediction of metabolic syndrome among postmenopausal Ghanaian women using obesity and atherogenic markers
Q33627755Regression models for log-normal data: comparing different methods for quantifying the association between abdominal adiposity and biomarkers of inflammation and insulin resistance
Q47703503Regression of Left Ventricular Mass After Bariatric Surgery
Q35582574Relation between C reactive protein concentrations and coronary microvascular endothelial function
Q34247249Relation between abdominal subcutaneous fat tissue thickness and inflammatory markers during pregnancy
Q73107480Relation of waist circumference and glycemic status to C-reactive protein in the Sandy Lake Oji-Cree
Q40728311Relations of Visceral and Abdominal Subcutaneous Adipose Tissue, Body Mass Index, and Waist Circumference to Serum Concentrations of Parameters of Chronic Inflammation
Q44916969Relationship between C-reactive protein and visceral adipose tissue in healthy Japanese subjects
Q48698039Relationship between high-sensitivity C-reactive protein and risk factors in patients with peripheral arterial disease--a cross-sectional study
Q34315210Relationship between lung function and metabolic syndrome
Q35904825Role of fibric acid derivatives in the management of risk factors for coronary heart disease
Q24594814Rosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease--a perspective
Q46465988Serum C-reactive protein and white blood cell count in morbidly obese surgical patients
Q37445314Serum C-reactive protein levels in normal-weight polycystic ovary syndrome
Q64890713Serum Uric Acid in Roma and Non-Roma-Its Correlation with Metabolic Syndrome and Other Variables.
Q37061136Serum amyloid A, but not C-reactive protein, stimulates vascular proteoglycan synthesis in a pro-atherogenic manner
Q43917196Severe hypertriglyceridemia with insulin resistance is associated with systemic inflammation: reversal with bezafibrate therapy in a randomized controlled trial
Q47131035Sonographically Assessed Intra-Abdominal Fat And Cardiometabolic Risk Factors in Adolescents with Extreme Obesity
Q46866093Stress-induced cytokine responses and central adiposity in young women
Q64998533Study of Visceral and Subcutaneous Abdominal Fat Thickness and Its Correlation with Cardiometabolic Risk Factors and Hormonal Parameters in Polycystic Ovary Syndrome.
Q57303564The TNF-α G-308A polymorphism is associated with C-reactive protein levels: The HERITAGE Family Study
Q48191813The association between obesity and fluid intelligence impairment is mediated by chronic low-grade inflammation
Q90116661The association of wrist circumference with hypertension in northeastern Chinese residents in comparison with other anthropometric obesity indices
Q37209774The concept of cardiometabolic risk: Bridging the fields of diabetology and cardiology
Q57892545The effects of body acupuncture on obesity: anthropometric parameters, lipid profile, and inflammatory and immunologic markers
Q35896629The epidemiology of central fat distribution in relation to disease
Q35146626The interaction of adiposity with the CRP gene affects CRP levels: age, gene/environment susceptibilty-Reykjavik study
Q40908186The interrelationships of birthweight, inflammation and body composition in healthy adults
Q51362473The relationship between high-sensitivity C-reactive protein and ApoB, ApoB/ApoA1 ratio in general population of China.
Q48316328The relationship between high-sensitivity C-reactive protein levels and the severity of obstructive sleep apnea
Q46978063The role of declining adaptive homeostasis in ageing
Q36859053The usefulness of circulating adipokine levels for the assessment of obesity-related health problems
Q35046184Time-dependent effects of safflower oil to improve glycemia, inflammation and blood lipids in obese, post-menopausal women with type 2 diabetes: a randomized, double-masked, crossover study
Q33840362Toll-like receptor 4 modulates skeletal muscle substrate metabolism
Q44529498Treatment of obesity: the need to target attention on high-risk patients characterized by abdominal obesity
Q53951145Tumour necrosis factor-alpha plasma levels in elderly patients with Type 2 diabetes mellitus-observations over 2 years.
Q92107971Type 2 diabetes mellitus, oxidative stress and inflammation: examining the links
Q36204530Urinary Malondialdehyde Is Associated with Visceral Abdominal Obesity in Middle-Aged Men
Q43168054Visceral adipose tissue and inflammation correlate with elevated liver tests in a cohort of overweight and obese patients
Q46025734Visceral adiposity and leptin are independently associated with C-reactive protein in Korean type 2 diabetic patients.
Q44570728Visceral fat accumulation determines postprandial lipemic response, lipid peroxidation, DNA damage, and endothelial dysfunction in nonobese Korean men.
Q40070943Visceral fat: a key mediator of steatohepatitis in metabolic liver disease.
Q47273955Waist circumference in determining obesity and hypertension among 18-60 years old Bengalee Hindu male slum dwellers in Eastern India
Q44548928Weight loss reduces tissue factor in morbidly obese patients

Search more.